{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:17:34Z","timestamp":1787509054000,"version":"build-2736575974"},"reference-count":77,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019531","name":"Apellis Pharmaceuticals","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100019531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2025,6,9]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Geographic atrophy (GA) is a form of advanced age-related macular degeneration (AMD) affecting approximately 1\u2009million people in the USA and 5\u2009million globally. In this review, retinal imaging techniques used for diagnosis and monitoring progression of GA in AMD, and the risk factors associated with the development and progression of GA are summarised. To familiarise clinicians with common phenotypes of patients with GA, the clinical and imaging features that may lead to rapid progression of GA in various phenotypes are highlighted. With the recent US Food and Drug Administration approval of new GA treatments that reduce lesion growth, understanding the risk of progression to GA and factors contributing to GA growth may aid in patient selection and guide patient-level management and treatment.<\/jats:p>","DOI":"10.1136\/bmjophth-2024-002105","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T07:50:12Z","timestamp":1751874612000},"page":"e002105","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct03525613","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03525600","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02503332","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02686658","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04435366","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5859-8162","authenticated-orcid":false,"given":"Rishi P","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3135-1922","authenticated-orcid":false,"given":"Christina Y","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W","family":"Kitchens","sequence":"additional","affiliation":[{"name":"Retina Associates of Kentucky, Lexington, Kentucky, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"Quilantan","sequence":"additional","affiliation":[{"name":"Apellis Pharmaceuticals Inc, Waltham, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Apellis UK Limited, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3651-8210","authenticated-orcid":false,"given":"Caroline R","family":"Baumal","sequence":"additional","affiliation":[{"name":"Apellis Pharmaceuticals Inc, Waltham, Massachusetts, USA"},{"name":"New England Eye Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Bay Area Retina Associates, Walnut Creek, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"2026010721210048000_10.1.e002105.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.08.038"},{"key":"2026010721210048000_10.1.e002105.2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.564"},{"key":"2026010721210048000_10.1.e002105.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.09.027"},{"key":"2026010721210048000_10.1.e002105.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.11.023"},{"key":"2026010721210048000_10.1.e002105.5","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/eye.2014.103","article-title":"How many people in England and Wales are registered partially sighted or blind because of age-related macular degeneration?","volume":"28","author":"Rees","year":"2014","journal-title":"Eye (Lond)"},{"key":"2026010721210048000_10.1.e002105.6","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S338253"},{"key":"2026010721210048000_10.1.e002105.7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/OPTH.S226425","article-title":"Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use","volume":"14","author":"Patel","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"2026010721210048000_10.1.e002105.8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ophtha.2017.11.036","article-title":"Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration","volume":"125","author":"Chakravarthy","year":"2018","journal-title":"Ophthalmology"},{"key":"2026010721210048000_10.1.e002105.9","doi-asserted-by":"crossref","first-page":"100213","DOI":"10.1016\/j.xops.2022.100213","article-title":"A Clinical and Preclinical Assessment of Clinical Trials for Dry Age-Related Macular Degeneration","volume":"2","author":"Abidi","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"2026010721210048000_10.1.e002105.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01520-9"},{"key":"2026010721210048000_10.1.e002105.11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajo.2017.03.031","article-title":"Geographic Atrophy and Foveal-Sparing Changes Related to Visual Acuity in Patients With Dry Age-Related Macular Degeneration Over Time","volume":"179","author":"Sayegh","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"2026010721210048000_10.1.e002105.12","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.198"},{"key":"2026010721210048000_10.1.e002105.13","unstructured":"Izervay [package insert]. Northbrook, IL Astellas Pharma; 2025."},{"key":"2026010721210048000_10.1.e002105.14","unstructured":"Syfovre [package insert]. Waltham, MA Apellis Pharmaceuticals, Inc; 2024."},{"key":"2026010721210048000_10.1.e002105.15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40267-024-01097-2","article-title":"Avacincaptad pegol in geographic atrophy secondary to age-related macular degeneration: a profile of its use","volume":"40","author":"Zhuang-Yan","year":"2024","journal-title":"Drugs Ther Perspect"},{"key":"2026010721210048000_10.1.e002105.16","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","article-title":"Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial","volume":"37","author":"Patel","year":"2023","journal-title":"Eye (Lond)"},{"key":"2026010721210048000_10.1.e002105.17","unstructured":"Goldberg RA , Kitchens JW , Lad E , et al . The evolving treatment paradigm in geographic atrophy. Retina Today; 2024."},{"key":"2026010721210048000_10.1.e002105.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01583-0"},{"key":"2026010721210048000_10.1.e002105.19","unstructured":"IZERVAY (avacincaptad pegol intravitreal solution) monthly or every other month reduced geographic atrophy lesion growth through 2 years [press release]. 2023. Available: https:\/\/www.astellas.com\/en\/news\/28646 [Accessed 16 Oct 2024]."},{"key":"2026010721210048000_10.1.e002105.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.12.002"},{"key":"2026010721210048000_10.1.e002105.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.05.021"},{"key":"2026010721210048000_10.1.e002105.22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2022.11.026","article-title":"Reticular Pseudodrusen Status, ARMS2\/HTRA1 Genotype, and Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report 32","volume":"130","author":"Agr\u00f3n","year":"2023","journal-title":"Ophthalmology"},{"key":"2026010721210048000_10.1.e002105.23","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.oret.2020.12.012","article-title":"Reticular Pseudodrusen in Late-Onset Retinal Degeneration","volume":"5","author":"Borooah","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"2026010721210048000_10.1.e002105.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2019.01.014"},{"key":"2026010721210048000_10.1.e002105.25","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1167\/iovs.16-20265","article-title":"Choroidal Thickness Influences Near-Infrared Reflectance Intensity in Eyes With Geographic Atrophy Due To Age-Related Macular Degeneration","volume":"57","author":"Dolz-Marco","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026010721210048000_10.1.e002105.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2011.02331.x"},{"key":"2026010721210048000_10.1.e002105.27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/ICU.0000000000000153","article-title":"Introduction to microperimetry and its use in analysis of geographic atrophy in age-related macular degeneration","volume":"26","author":"Hanout","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"2026010721210048000_10.1.e002105.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.11.041"},{"key":"2026010721210048000_10.1.e002105.29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.oret.2020.12.009","article-title":"Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 5","volume":"5","author":"Jaffe","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"2026010721210048000_10.1.e002105.30","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002182"},{"key":"2026010721210048000_10.1.e002105.31","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6075"},{"key":"2026010721210048000_10.1.e002105.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212563","article-title":"Choriocapillaris flow impairment surrounding geographic atrophy correlates with disease progression","volume":"14","author":"Nassisi","year":"2019","journal-title":"PLoS ONE"},{"key":"2026010721210048000_10.1.e002105.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.09.028"},{"key":"2026010721210048000_10.1.e002105.34","first-page":"919","article-title":"Therapeutic effect of pegcetacoplan on retinal pigment epithelium (RPE) and photoreceptor (PR) integrity in geographic atrophy (GA) in the phase III OAKS and DERBY trials","volume":"64","author":"Schmidt-Erfurth","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026010721210048000_10.1.e002105.35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000442784","article-title":"Optical Coherence Tomography Angiography of Dry Age-Related Macular Degeneration","volume":"56","author":"Waheed","year":"2016","journal-title":"Dev Ophthalmol"},{"key":"2026010721210048000_10.1.e002105.36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.oret.2022.01.011","article-title":"Diagnosing Persistent Hypertransmission Defects on En Face OCT Imaging of Age-Related Macular Degeneration","volume":"6","author":"Liu","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"2026010721210048000_10.1.e002105.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.09.035"},{"key":"2026010721210048000_10.1.e002105.38","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1159\/000530418","article-title":"Geographic Atrophy in AMD: Prognostic Factors Based on Long-Term Follow-Up","volume":"66","author":"Cedro","year":"2023","journal-title":"Ophthalmic Res"},{"key":"2026010721210048000_10.1.e002105.39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/jamaophthalmol.2021.6067","article-title":"Association of Pegcetacoplan With Progression of Incomplete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration: A Post Hoc Analysis of the FILLY Randomized Clinical Trial","volume":"140","author":"Nittala","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"2026010721210048000_10.1.e002105.40","first-page":"1502","article-title":"Patient characteristics from a post hoc analysis of nascent geographic atrophy progression following treatment with avacincaptad pegol from the GATHER1 study","volume":"63","author":"Danzig","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026010721210048000_10.1.e002105.41","doi-asserted-by":"crossref","first-page":"100306","DOI":"10.1016\/j.xops.2023.100306","article-title":"Geographic Atrophy in Age-Related Macular Degeneration: A Tale of Two Stages","volume":"3","author":"Keenan","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"2026010721210048000_10.1.e002105.42","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.oret.2022.03.022","article-title":"Adherence to a Mediterranean Diet and Geographic Atrophy Enlargement Rate: Age-Related Eye Disease Study 2 Report 29","volume":"6","author":"Agr\u00f3n","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"2026010721210048000_10.1.e002105.43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajo.2021.10.032","article-title":"Optical Coherence Tomography Measurements of the Retinal Pigment Epithelium to Bruch Membrane Thickness Around Geographic Atrophy Correlate With Growth","volume":"236","author":"Chu","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"2026010721210048000_10.1.e002105.44","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.oret.2023.05.004","article-title":"Progression Dynamics of Early versus Later Stage Atrophic Lesions in Nonneovascular Age-Related Macular Degeneration Using Quantitative OCT Biomarker Segmentation","volume":"7","author":"Coulibaly","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"2026010721210048000_10.1.e002105.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.07.047"},{"key":"2026010721210048000_10.1.e002105.46","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1167\/iovs.19-26589","article-title":"The Fate and Prognostic Implications of Hyperreflective Crystalline Deposits in Nonneovascular Age-Related Macular Degeneration","volume":"60","author":"Fragiotta","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026010721210048000_10.1.e002105.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.08.002"},{"key":"2026010721210048000_10.1.e002105.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.05.028"},{"key":"2026010721210048000_10.1.e002105.49","doi-asserted-by":"crossref","first-page":"100160","DOI":"10.1016\/j.xops.2022.100160","article-title":"Machine Learning OCT Predictors of Progression from Intermediate Age-Related Macular Degeneration to Geographic Atrophy and Vision Loss","volume":"2","author":"Lad","year":"2022","journal-title":"Ophthalmology Science"},{"key":"2026010721210048000_10.1.e002105.50","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1167\/iovs.16-20781","article-title":"Prevalence, Natural Course, and Prognostic Role of Refractile Drusen in Age-Related Macular Degeneration","volume":"58","author":"Oishi","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2026010721210048000_10.1.e002105.51","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.2914"},{"key":"2026010721210048000_10.1.e002105.52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3928\/23258160-20211210-01","article-title":"Risk Classification for Progression to Subfoveal Geographic Atrophy in Dry Age-Related Macular Degeneration Using Machine Learning\u2013Enabled Outer Retinal Feature Extraction","volume":"53","author":"Sarici","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"2026010721210048000_10.1.e002105.53","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-24106"},{"key":"2026010721210048000_10.1.e002105.54","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317636"},{"key":"2026010721210048000_10.1.e002105.55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ajo.2020.12.015","article-title":"Correlations Between Choriocapillaris and Choroidal Measurements and the Growth of Geographic Atrophy Using Swept Source OCT Imaging","volume":"224","author":"Shi","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"2026010721210048000_10.1.e002105.56","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ophtha.2017.06.032","article-title":"Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration","volume":"124","author":"Sleiman","year":"2017","journal-title":"Ophthalmology"},{"key":"2026010721210048000_10.1.e002105.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.08.047"},{"key":"2026010721210048000_10.1.e002105.58","doi-asserted-by":"publisher","DOI":"10.1159\/000510507"},{"key":"2026010721210048000_10.1.e002105.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.06.034"},{"key":"2026010721210048000_10.1.e002105.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.08.018"},{"key":"2026010721210048000_10.1.e002105.61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2022.08.012","article-title":"Does the Outer Retinal Thickness Around Geographic Atrophy Represent Another Clinical Biomarker for Predicting Growth?","volume":"244","author":"Zhang","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"2026010721210048000_10.1.e002105.62","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90340-8"},{"key":"2026010721210048000_10.1.e002105.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.09.016"},{"key":"2026010721210048000_10.1.e002105.64","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ophtha.2015.03.027","article-title":"Directional Kinetics of Geographic Atrophy Progression in Age-Related Macular Degeneration with Foveal Sparing","volume":"122","author":"Lindner","year":"2015","journal-title":"Ophthalmology"},{"key":"2026010721210048000_10.1.e002105.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2022.08.003"},{"key":"2026010721210048000_10.1.e002105.66","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2022-322672"},{"key":"2026010721210048000_10.1.e002105.67","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/diagnostics13061178","article-title":"Automated Identification and Segmentation of Ellipsoid Zone At-Risk Using Deep Learning on SD-OCT for Predicting Progression in Dry AMD","volume":"13","author":"Kalra","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"2026010721210048000_10.1.e002105.68","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.12.11"},{"key":"2026010721210048000_10.1.e002105.69","first-page":"S2","article-title":"Geographic atrophy: Mechanism of disease, pathophysiology, and role of the complement system","volume":"29","author":"Bakri","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"2026010721210048000_10.1.e002105.70","unstructured":"Singerman LJ OAKS DaGI 24-month results from the gale open-label extension study: 48 months of continuous pegcetacoplan. Presented at: Annual Meeting of the Macula Society; February 12-15; 2025"},{"key":"2026010721210048000_10.1.e002105.71","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.10.1417"},{"key":"2026010721210048000_10.1.e002105.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2025.02.012"},{"key":"2026010721210048000_10.1.e002105.73","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.oret.2020.11.003","article-title":"Relationship of Topographic Distribution of Geographic Atrophy to Visual Acuity in Nonexudative Age-Related Macular Degeneration","volume":"5","author":"Shen","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"2026010721210048000_10.1.e002105.74","doi-asserted-by":"publisher","DOI":"10.4274\/tjo.28003"},{"key":"2026010721210048000_10.1.e002105.75","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01554-2"},{"key":"2026010721210048000_10.1.e002105.76","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30079-7"},{"key":"2026010721210048000_10.1.e002105.77","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.oret.2020.01.012","article-title":"Progression from Early\/Intermediate to Advanced Forms of Age-Related Macular Degeneration in a Large UK Cohort: Rates and Risk Factors","volume":"4","author":"Chakravarthy","year":"2020","journal-title":"Ophthalmol Retina"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2024-002105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:21:57Z","timestamp":1767849717000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2024-002105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7,7]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjophth-2024-002105"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2024-002105","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}